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INTRODUCTION
Opioid analgesics continue to be the mainstay of pharmacologic treatment of moderate to
severe pain. An adjunct is a drug that in its pharmacological characteristic is not identified
primarily as an analgesic, but that has been found in clinical practice to have either an
independent analgesic effect or additive analgesic properties when used with opioids. By using
an adjunct to maximize the level of analgesia, the required opioid dosage may be reduced,
together with concomitant adverse effects.
BACKGROUND
Real World Data (RWD) refers to data that describe observations in normal clinical practice
obtained by any non-interventional methodology, such as Randomized Controlled Trials (RCTs).
The U.S. Food and Drug Administration (FDA) maintains one of the largest government
databases in the country, the FDA Adverse Event Reporting System (FAERS). It is comprised of
adverse event reports submitted to the FDA through the “MedWatch” reporting program and
contains a plethora of Real World Data: thousands of case reports on opioids and adjunct drugs,
comprised of unstructured textual data. The objective of this study is to identify the therapeutic
effectiveness of adjunct drugs with opioids by examination of narrative text in MedWatch cases.
METHODS
This project follows the traditional approach of knowledge discovery in databases, comprised
of five steps: 1) Data selection, 2) Pre-processing, 3) Transformation, 4) Data mining and 5)
Interpretation. The strategy employed will transform the narrative text data into an organized and

concise summary of key endpoints. An appropriate sample (500 to 1,000 relevant patient cases)
that describe opioids and adjunct drugs will be included in the case report data set.
Key task 1: Data selection and pre-processing (Steps 1,2). MedWatch narratives of patient
cases that describe the types of opioid and adjunct drug combinations used in real-life clinical
settings will be obtained from the FAERS database. Key task 2: Data transformation and mining
(Steps 3,4). Cases will be organized in a Structured Query Language (SQL) database. A lexicon
of words and terms clinically or theoretically related to opioid and adjunct drug therapy will be
developed, which will serve as a reference for analysis of the text. Using Natural Language
Processing (NLP) techniques, textual data will be transformed into n-grams using a MySQL ngram parser. N-gram extraction will identify notes containing n-grams matching terms from the
theory-and expert-derived lexicon. Categories will be formed from the most frequently identified
n-grams and their total frequency.
RESULTS (PROJECTED)
Key task 3: Evaluate and interpret results (Step 5) and compile the information into a useful
format for healthcare providers. The most commonly extracted n-grams will be identified by
category, then frequency, and displayed in tabular format. N-gram analysis of the corpus of case
reports reveals the frequency with which and adjunct drug was used with an opioid, and indicate
impact on analgesic effect. Completion of key tasks provides evidence on the associated
outcomes of treatment; whether the adjunct drug therapy indicates treatment success or failure.
CONCLUSION
Findings of this project will add to the existing body of knowledge on opioid adjunct therapy
for analgesia and may corroborate or refute other existing evidence for adjunct drug therapeutic
effectiveness derived from case reports or clinical trials.

